Dry needling and shoulder impingement syndrome

Study the effect of dry needling of supraspinatus muscle on the management of patients with impingement syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201601234203N10

Enrollment

Registered

2016-03-02

Start date

2016-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impingement syndrome of shoulder. Impingement syndrome of shoulder

Interventions

Intervention 1: Control group: No intervention. Intervention 2: Intervention group: Inserting of dry needling into trigger point of supraspinatus muscle with a 0.2 mm diameter and 4 mm length needle,

Treatment - Drugs

Treatment - Other

Control group: No intervention

Intervention group: Inserting of dry needling into trigger point of supraspinatus muscle with a 0.2 mm diameter and 4 mm length needle, lasting for 2 minutes.

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who suffer from shoulder painat the proximal and antero-lateral aspect of shoulder region lasting more than 1-week; Having at least one positive impingement test. Exclusion criteria: Fibromyalgia; Pregnancy; Traumatic onset of symptoms; Other histoy of shoulder injury; Torn tendons; Ligamentous laxity; Numbness or tingling in the upper extremity; History of shoulder or neck surgery; Systemic diseases; BMI > 28; History of steroid injection 3 months before intervention; History of physiotherapy 6 months before intervention; Depression; Taking analgesics or muscle relaxants 72 hours befor examination; Complete tear of rotator cuff muscles diagnosed with ultrasonography; Frozen shoulder. Frozen shoulder

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before intervention, Immediately after intervention, 10 days after intervention. Method of measurement: VAS.;Shoulder range of motion. Timepoint: befor intervention, Immediately after intervention, 10 days after intervention. Method of measurement: Goniometery.;Shoulder function. Timepoint: befor intervention-10 days after intervention. Method of measurement: Shoulder performance questionnaire.	—

Measure

Time frame

Pain. Timepoint: Before intervention, Immediately after intervention, 10 days after intervention. Method of measurement: VAS.;Shoulder range of motion. Timepoint: befor intervention, Immediately after intervention, 10 days after intervention. Method of measurement: Goniometery.;Shoulder function. Timepoint: befor intervention-10 days after intervention. Method of measurement: Shoulder performance questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Atefeh Aminian Far

Semnan University of Medical Sciences

aminfar@semums.ac.iraminfar83@yahoo.com+98 23 3365 4180

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026